Monitoring the efficacy of artemether-lumefantrine for the treatment of uncomplicated malaria in Malawian children

BACKGROUND: The resistance of malaria parasites to sulphadoxine-pyrimethamine (SP) in 2007 led to the Malawi Ministry of Health changing to artemether-lumefantrine (AL) as first-line for uncomplicated malaria treatment. This study determined the efficacy and safety of AL for the treatment of uncompl...

Descripción completa

Detalles Bibliográficos
Autores principales: Dambe, Rosalia, Sande, John, Ali, Doreen, Chilima, Ben, Dodoli, Wilfred, Michelo, Charles, Malenga, Grace, Phiri, Kamija S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4409988/
https://www.ncbi.nlm.nih.gov/pubmed/25902780
http://dx.doi.org/10.1186/s12936-015-0701-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4409988/
https://www.ncbi.nlm.nih.gov/pubmed/25902780
http://dx.doi.org/10.1186/s12936-015-0701-8

Ejemplares similares